Concepedia

Tadayasu Okazaki

TO

Statistics

Publications

8

Citations

229

H-Index

8

Active since

1984

Affiliations

Taisho Pharmaceutical (Japan)(Current)

Tadayasu Okazaki is an author at Taisho Pharmaceutical (Japan) specializing in drug discovery, pharmacy, and medicinal chemistry.

Publications per year

1984–2004

8

Publications

8

Isolation and Characterization of a New Pyrano(4',3':6,7)naphtho(1,2-b)xanthene Antibiotic FD-594.

Ya-Fang QIAO, Tadayasu Okazaki, Tsutomu Ando et al. · The Journal of Antibiotics · 1998 · 53 citations · Full text

, , +4

Isolation and characterization of a new 12-membered macrolide FD-895.

MITSUKO SEKI-ASANO, Tadayasu Okazaki, Michio Yamagishi et al. · The Journal of Antibiotics · 1994 · 47 citations · Full text

, , +6

Xantholipin, a novel inhibitor of HSP47 gene expression produced by Streptomyces sp.

Yuichi Terui, LI Jun-ying, Tsutomu Ando et al. · Tetrahedron Letters · 2003 · 39 citations

, , +4

Isolation and characterization of new 18-membered macrolides FD-891 and FD-892.

MITSUKO SEKI-ASANO, Tadayasu Okazaki, Michio Yamagishi et al. · The Journal of Antibiotics · 1994 · 34 citations · Full text

, , +5

A Novel Bioactive .DELTA. lactone FD-211 Taxonomy, Isolation and Characterization.

Osamu Nozawa, Tadayasu Okazaki, Noriyoshi Sakai et al. · The Journal of Antibiotics · 1995 · 24 citations · Full text

, , +5

1–5 of 8